Trials / Completed
CompletedNCT02708004
Clinical Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy Subjects
A Single-center, Double-blind, Randomized, Placebo-controlled, Two-way Crossover Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Idorsia Pharmaceuticals Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This clinical study will be conducted to evaluate the effect of ACT-132577 on fluid homeostasis in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aprocitentan | Formulated in capsules in 2 different strengths; 2 capsules per day |
| OTHER | Placebo | Matching active drug |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2016-03-15
- Last updated
- 2022-11-29
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02708004. Inclusion in this directory is not an endorsement.